Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Not yet recruiting 1Active not recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Carcinoma, Non-Small-Cell Lung 6Rectal Neoplasms 3Lung Neoplasms 2Carcinoma, Hepatocellular 2Upper Tract Urothelial Carcinoma 1Unresectable Hepatocellular Carcinoma 1Turcot syndrome 1Triple Negative Breast Neoplasms 1Solid Tumor Cancer 1Sarcoma 1Radiation Injuries 1Pathologic Complete Response 1Pancreatic Cancer Liver Metastases 1Neoadjuvant Immunotherapy 1Muscle-invasive Bladder Cancer 1Locally Advanced Rectal Adenocarcinoma 1Locally Advanced Pancreatic Cancer 1Locally Advanced Cervical Carcinoma 1Hyperthermia 1HER2-Negative Locally Advanced Breast Cancer 1Gynecologic Cancers 1Gastrointestinal Neoplasms 1Gastric Cancer With Liver Metastases 1Esophageal Squamous Cell Carcinoma 1Efficacy and Safety of Short-course Radiotherapy in Total Neoadjuvant Therapy Combined With Enlonstobart for pMMR Locally Advanced Rectal Cancer 1Colorectal Neoplasms 1Carcinoma 1Breast Neoplasms 1Advanced Rectal Cancer 1

Interventions

trametinib 1semaglutide 1dabrafenib 1Surveys and Questionnaires 1Specimen Handling 1Pemetrexed 1Immunotherapy 1Endoscopic Mucosal Resection 1Educational Status 1Diathermy 1Blood Specimen Collection 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Not yet recruiting × Gastrointestinal Neoplasms × Immunotherapy × Clear all
NCT07118566 2025-08-12

Hyperthermia Combined With Immune Checkpoint Inhibitors in the Treatment of Advanced Gastrointestinal Malignancies With Liver Metastases

China Medical University, China

Phase 2 Not yet recruiting
40 enrolled
Gastrointestinal

Hyperthermia, Gastrointestinal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡